Hand Dermatoses Clinical Trial
Official title:
Efficacy and Safety of BAL4079 in the Treatment of Severe Refractory Chronic Hand Dermatitis
The purpose of the study is to determine the therapeutic effect of alitretinoin, a retinoid, on severe, therapy refractory chronic hand dermatitis.
Chronic hand dermatitis (CHaD) is a frequent and distressing disease. Conventional treatments yield mostly unsatisfactory results. In addition, chronic hand dermatitis leads to 2-5% of all applications for permanent disability pensions in some western countries. In a therapeutic dose finding study alitretinoin was clinically effective for patients with moderate to severe chronic hand dermatitis refractory to topical treatment. Patients with severe refractory CHaD will be allocated either of two active treatments or placebo. The primary objective is to demonstrate the response rate based on physicians global assessment of the disease. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00124436 -
Follow-up Efficacy and Safety of Alitretinoin in Severe Chronic Hand Dermatitis
|
Phase 3 | |
| Completed |
NCT04136574 -
Hand Dermatitis in the Care and Hospital Staff
|
||
| Completed |
NCT03617068 -
The Effectiveness of Coconut Oil Cream as a Prevention Treatment for Occupational Hand Dermatitis Among Batik Workers
|
Phase 3 | |
| Completed |
NCT05471934 -
Satisfaction Survey - Cicaplast Mains
|
||
| Completed |
NCT00890968 -
Safety and Efficacy Study of Triamcinolone Acetonide DuraPeel to Treat Hand Dermatitis
|
Phase 2 | |
| Completed |
NCT00309621 -
Safety and Efficacy of a Retinoid for the Treatment of Severe Chronic Hand Dermatitis
|
Phase 3 |